Youth who lose their ASD diagnosis may have subtle social and communication difficulties. We examined social and communication functioning in 44 high-functioning autism (HFA), 34 optimal outcome (OO) and 34 typically developing (TD) youth. Results indicated that OO participants had no autism communication symptoms, no pragmatic language deficits, and were judged as likable as TD peers. Some group differences were found: OO youth had less insight into social relationships and poorer friendship descriptions than TD youth. OO participants had attention, self-control, and immaturity difficulties that may impact social abilities. However, OO participants were most engaged, friendliest, warmest, and most approachable. Overall, OO participants had no social and communicative impairments, although some exhibited mild social difficulties that often accompany attentional problems.

formulary. 3) Understand the current activities and initiatives of CDC's Strategic National Stockpile to enhance the nation's preparedness for an emergency response requiring rapid deployment and utilization of MCMs. Background: The United States is prepared for responding to national health security threats from chemical, biological, radiological, and nuclear (CBRN) agents, and emerging infectious diseases. Under the leadership of the US Department of Health and Human Services (HHS), the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) is the federal coordinating body that reviews the SNS contents and makes MCM formulary recommendations annually. MCMs are held in the Centers for Disease Control and Prevention (CDC) Strategic National Stockpile (SNS), which contains a broad range of emergency medical countermeasures. The Division of Strategic National Stockpile (DSNS) works across the medical supply chain to ensure that stockpiled MCMs are maintained and are available for deployment on short notice, and that capabilities exist to rapidly distribute and dispense these MCMs. This session will address the mission and capabilities of the SNS, including: Federal prioritization process for current and planned medical countermeasure procurement and stockpiling; Ongoing work to ensure state and local capabilities exist to receive and dispense MCMs to their populations in an emergency response; Engagement with the private sector medical supply chain to improve access to limited MCM resources; and Current SNS capabilities to support state and local response to a public health emergency. Methods: Not applicable. Results: Not applicable. Conclusion: This session will describe the role and capabilities of CDC's SNS to meet the nation's requirements for MCMs in a public health emergency. These processes may be scalable and adaptable to other countries performing stockpiling activities.

No abstract

No abstract

dology and analysis of qualitative free text responses, as well as subsequent systematic literature reviews and ethical analysis of identified core issues. An international perspective is presented, with the use of a New Zealand health system exemplar. Results: There are specific risks associated with current responses to patient redirectionthese include clinical, professional, legal and ethical risks. These risks are disproportionately spread across the key stakeholders in this process (patients, medical staff, managers), with limited recognition of these risks. Conclusion: There is insufficient research and audit follow-up associated with the introduction of many overcrowding mitigation processes. Tendencies exist to focus on a 'quick fix', a highly visible responses to manage primary care patients, which may not be the best use of resources.